首页>
外国专利>
MDM2 inhibitors for treating uveal melanoma
MDM2 inhibitors for treating uveal melanoma
展开▼
机译:MDM2抑制剂治疗葡萄膜黑色素瘤
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure relates to a pharmaceutical combination, e.g. a product, comprising a combination of (a) a MDM2 inhibitor of formula I or formula II, or a pharmaceutically acceptable salt thereof and a PKC pathway inhibitor of formula III, formula IV, formula V or formula VI or a pharmaceutically acceptable salt thereof, particularly for use in the treatment or prevention of proliferative diseases. The disclosure also relates to corresponding pharmaceutical formulations, uses, methods, combinations, data carriers and related disclosure embodiments. The disclosure further relates to use of an MDM2 inhibitor of formula I or formula II, or a pharmaceutically acceptable salt thereof, alone for use in the treatment of a proliferative disease.
展开▼